Gentamicin And Ciprofloxacin Sensitivity Against E. Coli Clinically Isolated From Urinary Tract Infection
DOI:
https://doi.org/10.46966/msjar.v4i3.132Keywords:
Urinary Tract Infection, E. Coli, Ciprofloxacin, Gentamicin, Antimicrobial AgentsAbstract
Background: Escherichia coli (E. coli) is common bacteria that can be pathogenic and develop resistance to various antibiotics by different ways, making them difficult to treat with standard therapies. So monitoring antibiotic resistance is urgent. Material and methods: E. coli was isolated from urinary tract and cultured in three media (blood agar, macConkey agar, and EMB agar), then they were incubated for 24 hours at a temperature of 37oC to grow. The antibiotics discs (Ciprofloxacin, Gentamicin) were used by disc diffusion method. All the statistical analysis was done by using SPSS 26 software and Excel app. Results: The participants in this study were 70% women, while 30% were men with significant differences (P< 0.05). Gentamicin showed high rate of sensitivity (85%). The sensitive isolates to ciprofloxacin were 75%. Conclusions: We have found that 85% of bacteria are sensitive to gentamicin, and thus it can be used as an empirical treatment. Ciprofloxacin showed high rate of sensitivity against E. coli 75%.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Falah AL-Khikani
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
